FDA Warns John Wayne Cancer Institute On Clinical Trial Procedures
This article was originally published in The Pink Sheet Daily
Executive Summary
The trial cited in an FDA warning letter involved a cancer vaccine for which CancerVax now holds the IND. The institute says it will publicly post a response to the warning letter with its planned procedural changes.